Micardis and Psoriasis - a phase IV clinical study of FDA data
Summary:
Psoriasis is reported as a side effect among people who take Micardis (telmisartan), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Humira, and have Psoriatic arthropathy.
The phase IV clinical study analyzes which people have Psoriasis when taking Micardis. It is created by eHealthMe based on reports of 26,556 people who have side effects when taking Micardis from the FDA, and is updated regularly.
What is Micardis?
Micardis has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 27,605 Micardis users. Check the latest studies of Micardis.
What is Psoriasis?
Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 1,478 drugs and 1,694 conditions by eHealthMe. Check the latest studies of Psoriasis.
26,556 people reported to have side effects when taking Micardis.
Among them, 121 people (0.46%) have Psoriasis.
Among these 121 people:
How long have people been on Micardis when they have Psoriasis? *
What is the gender of people who have Psoriasis when taking Micardis? *
What is the age of people who have Psoriasis when taking Micardis? *
What are other drugs people take besides Micardis? *
What are other side effects people have besides Psoriasis? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Micardis and have Psoriasis?
- Check whether Psoriasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Micardis:
- Micardis (27,605 reports)
Psoriasis treatments and more:
- Psoriasis (508,164 reports)
How severe was Psoriasis and when was it recovered:
Expand to all the drugs that have ingredients of telmisartan:
- Psoriasis and drugs with ingredients of telmisartan (387 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Micardis:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Psoriasis:
- Psoriasis (1,478 drugs)
Browse all the conditions that are associated with Psoriasis:
- Psoriasis (1,694 conditions)
Related publications that referenced our studies
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
- Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
- Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
- Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
- Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on telmisartan (the active ingredients of Micardis) and Micardis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Tramadol and Polyethylene Glycol 3350 - a second ago
- Dexamethasone Sodium Phosphate and Sulfamethoxazole And Trimethoprim drug interactions for women aged 60+ - 3 seconds ago
- Avastin and Tresiba drug interactions for men aged 60+ - 9 seconds ago
- Gastrointestinal Stromal Tumor and Swelling Face - 13 seconds ago
- Tapentadol and Naloxone drug interactions for men aged 30-39 - 15 seconds ago
- Could Daypro cause Muscle Aches? - 16 seconds ago
- Skin Disorder and drugs of ingredients of buprenorphine hydrochloride; naloxone hydrochloride - 18 seconds ago
- Cardiac Stress Test Abnormal and drugs of ingredients of metformin hydrochloride - 23 seconds ago
- Breast Cancer Metastatic and Sciatica - 25 seconds ago
- Zolpidem and Losartan drug interactions for men aged 60+ - 34 seconds ago